phase readout
saveNCT07301424: Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
NOT_YET_RECRUITINGupdated 1h ago
community read0 votes
Sponsor: University of Alberta. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia
view source ↗
comments(0)
5-min edit window · permanent after that